|
|
| Start | Technology | The Company | Contact |
|
Welcome to StratoSphere Pharma
Our mission is to provide the StratoSphereHL™ technology to the global pharma and biotech industry, thereby accelerating and facilitating the development of safe and effective sustained release injectables for proteins, peptides and small molecule drugs. StratoSphereHL™ is a microsphere technology comprising approved excipients and a robust manufacturing process, eliminating the well-known burst problem yet allowing the addition of a record high ~40% drug load. And some 15-20 years to your patent protection! It has been estimated that the global R&D pipeline hosts more than 500 protein and peptide drugs, as well as numerous small molecules, for which such a reliable, sustained release technology will be either a prerequisite or a competitive edge. In addition, a number of marketed drugs await life cycle management, from once daily injections to sustained release.
Is one of these drugs yours? Let's talk... (Contact)
|
|
StratoSphere Pharma AB POBox 50226 SE-202 12 Malmö, Sweden |
Phone: +46 40 18 35 75 E-mail: |
Produced by Ahltorp Media AB |